Key result
Combined very low-attenuation CTA plaque and attenuated IVUS plaque predicts no-reflow with ~96% accuracy.
Why the study?
Does the combination of CTA and IVUS improve the prediction of no-reflow phenomenon after percutaneous coronary stenting in stable CAD patients?
Observational (n=707)
No
Does the combination of CTA and IVUS improve the prediction of no-reflow phenomenon after percutaneous coronary stenting in stable CAD patients?
Absolute Event Rate: 31.7% vs 0.3%
p-value: p=<0.001
Combining CTA and IVUS plaque characterization significantly improves the predictive accuracy for no-reflow phenomenon during PCI in stable CAD patients.
May aid no-reflow risk stratification during PCI in stable CAD; leaves open whether combined imaging should guide practice.
Attenuated plaque on intravascular ultrasound (IVUS) and low attenuation plaque on computed tomography angiography (CTA) are associated with no-reflow phenomenon during percutaneous coronary intervention (PCI). However, evaluation by a single modality has been unable to satisfactorily predict this phenomenon. We investigated whether the combination of IVUS and CTA findings can ameliorate the predictive potential for no-reflow phenomenon after stent implantation during PCI in stable coronary artery disease (CAD). A total of 988 lesions of 707 stable CAD patients who underwent coronary CTA before PCI were enrolled. PCI was performed with preprocedural IVUS and stent implantation. As for plaque characters, very low attenuation plaque (CTA v-LAP) whose minimum density was < 0 Hounsfield units on CTA and attenuated plaque (IVUS AP) on IVUS were evaluated. No-reflow phenomenon was observed in 22 lesions (2.2%) of 19 patients (2.7%). Both CTA v-LAP and IVUS AP were much more frequently observed in patients with no-reflow phenomenon. Positive (PPV) and negative predictive values (NPV) and accuracy for prediction of no-reflow were almost equivalent between CTA v-LAP (13.2, 99.6, and 87.0%) and IVUS AP (15.7, 99.8, and 89.0%). The combination of CTA v-LAP and IVUS AP markedly ameliorated PPV (31.7%) without deterioration of NPV (99.7%) and increased the diagnostic accuracy (95.5%). These findings showed that the combination of CTA v-LAP and IVUS AP improved the predictive power for no-reflow phenomenon after coronary stenting in stable CAD patients, suggesting the usefulness of combined estimation by using CTA and IVUS for predicting no-reflow phenomenon during PCI in clinical practice.
No takes yet. Share an insight, caveat, or question.
Okutsu et al. (2018) conducted an observational in Stable coronary artery disease (n=707). Combination of CTA very low attenuation plaque (v-LAP) and IVUS attenuated plaque (AP) vs. Absence of combined CTA v-LAP and IVUS AP was evaluated on No-reflow phenomenon (p=<0.001). The combination of very low attenuation plaque on CTA and attenuated plaque on IVUS predicted no-reflow phenomenon with a positive predictive value of 31.7% and an accuracy of 95.5%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: